Aurobindo Accesses Russian OTC Market Through Deal With Diod
This article was originally published in PharmAsia News
Executive Summary
Indian company Aurobindo Pharma has staked a claim in Russia's surging consumer health product market with a joint venture to market OTC and generic drugs